Cargando…
A Yeast/Drosophila Screen to Identify New Compounds Overcoming Frataxin Deficiency
Friedreich's ataxia (FA) is a rare neurodegenerative disease which is very debilitating for the patients who progressively lose their autonomy. The lack of efficient therapeutic treatment of the disease strongly argues for urgent need to search for new active compounds that may stop the progres...
Autores principales: | Seguin, Alexandra, Monnier, Véronique, Palandri, Amandine, Bihel, Frédéric, Rera, Michael, Schmitt, Martine, Camadro, Jean-Michel, Tricoire, Hervé, Lesuisse, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619980/ https://www.ncbi.nlm.nih.gov/pubmed/26523199 http://dx.doi.org/10.1155/2015/565140 |
Ejemplares similares
-
Identification of cardioprotective drugs by medium-scale in vivo pharmacological screening on a Drosophila cardiac model of Friedreich's ataxia
por: Palandri, Amandine, et al.
Publicado: (2018) -
Human mitochondrial ferritin improves respiratory function in yeast mutants deficient in iron–sulfur cluster biogenesis, but is not a functional homologue of yeast frataxin
por: Sutak, Robert, et al.
Publicado: (2012) -
A New, Discontinuous 2 Phases of Aging Model: Lessons from Drosophila melanogaster
por: Tricoire, Hervé, et al.
Publicado: (2015) -
dJun and Vri/dNFIL3 Are Major Regulators of Cardiac Aging in Drosophila
por: Monnier, Véronique, et al.
Publicado: (2012) -
Genome wide analysis of common and specific stress responses in adult drosophila melanogaster
por: Girardot, Fabrice, et al.
Publicado: (2004)